Tanabe Seiyaku Co., Ltd.
Records under this name other than patents Tanabe Seiyaku Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Tanabe Seiyaku Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,943,788 | Glucopyranoside Compound Formerly held In force · High confidence | In force | High confidence | |
| US 7,872,126 | Tetrahydroquinoline derivatives and a process for preparing the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,572,630 | Method for differentiating primate embryonic stem cell into vascular cell Formerly held Term ended Term ended Jun 15, 2026 · USPTO record | Term ended | Term ended Jun 15, 2026 | USPTO record |
| US 6,656,935 | Aromatic nitrogen-containing 6-membered cyclic compounds Formerly held Term ended Term ended Apr 27, 2025 · USPTO record | Term ended | Term ended Apr 27, 2025 | USPTO record |
| US 8,158,640 | Tetrahydroquinoline derivatives and a process for preparing the same Formerly held Term ended Term ended Apr 1, 2025 · USPTO record | Term ended | Term ended Apr 1, 2025 | USPTO record |
| US 8,362,274 | Arylalkylamine Compound and Process for Preparing the Same Formerly held Lapsed on the fee record Ended Jan 29, 2025 · High confidence | Lapsed on the fee record | Ended Jan 29, 2025 | High confidence |
| US 7,501,409 | Preparations for oral administration Formerly held Term ended Term ended May 5, 2023 · USPTO record | Term ended | Term ended May 5, 2023 | USPTO record |
| US 8,809,360 | Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions Formerly held Lapsed on the fee record Ended Aug 19, 2022 · USPTO record | Lapsed on the fee record | Ended Aug 19, 2022 | USPTO record |
| US 7,759,373 | Large conductance calcium-activated K channel opener Formerly held Lapsed on the fee record Ended Jul 20, 2022 · USPTO record | Lapsed on the fee record | Ended Jul 20, 2022 | USPTO record |
| US 6,730,702 | Therapeutic agents for inflammatory diseases of intestine Term ended Term ended Jun 7, 2022 · USPTO record | Term ended | Term ended Jun 7, 2022 | USPTO record |